[Current antalgic anti-inflammatory drugs].
D000893:Anti-Inflammatory Agents; D001623:Betamethasone / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000139:chemically induced; D005128:Eye Diseases / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007239:Infections; D007249:Inflammation / Q000188:drug therapy; D007592:Joint Diseases / Q000139:chemically induced; D008659:Metabolic Diseases / Q000139:chemically induced; D008775:Methylprednisolone / Q000627:therapeutic use; D009135:Muscular Diseases / Q000139:chemically induced; D009461:Neurologic Manifestations; D010248:Paramethasone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012877:Skin Manifestations; D014221:Triamcinolone / Q000627:therapeutic use; D014652:Vascular Diseases / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014221:Triamcinolone; D003907:Dexamethasone; D001623:Betamethasone; D011239:Prednisolone; D003348:Cortisone; D011241:Prednisone; D010248:Paramethasone; D006854:Hydrocortisone; D008775:Methylprednisolone
Les médications anti-inflammatoires antalgiques courantes.